Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Torrent Pharmaceuticals Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Nov 2002 on NSE
Last close ₹4,613.40up ₹33.40 (0.73%)BSE ₹4,635.15
Share price at the NSE close on 30 Oct 2026. Previous close ₹4,580.00.
30 Oct: open ₹4,560.00, high ₹4,672.00, low ₹4,532.00
52-week range of traded prices to 30 Oct 2026
₹3,532.60Low, 6 Nov 2025₹5,250.00High, 3 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,75,479 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.62
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.82%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,36,64564.6% delivered
Torrent Pharmaceuticals share news and announcements
865 announcements, routine notices left out, newest first. Page 15 of 18.
Jan 2015
15 Jan · Corporate action
Company has fixed Record Date as February 3, 2015 for the purpose of payment of Interim Dividend.
Dec 2014
26 Dec · Legal
Exchange has sought clarification from Torrent Pharmaceuticals Limited with respect to recent news item captioned "Torrent Pharma in pact with Reliance Life to sell biosimilars". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.
Nov 2014
Oct 2014
1 Oct · Board meeting
Inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2014. Further, as per the provisions of the Insider Trading Code of the Company, the trading window will remain closed between October 01, 2014 to November 06, 2014 (Board meeting for, inter alia, considering above results being held on November 05, 2014).
Aug 2014
1 Aug · Disclosure of Voting Pattern - Clause 35A
Jul 2014
31 Jul · Business
9 Jul · Meeting
Annual General Meeting of the company will be held on July 30, 2014.
Jun 2014
30 Jun · Board meeting
Inter-alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for quarter ended June 30, 2014. Further the Company has informed that as per the provisions of the Insider Trading Code of the Company, the trading window will remain closed between July 01, 2014 to July 31, 2014 (Board meeting for, inter-alia, considering above results being held on July 30, 2014).
May 2014
12 May · Corporate action
Share Transfer Books and Register of Members of the Company will remain closed from June 18, 2014 to June 20, 2014 (both days inclusive) for the purpose of final dividend for the year ended March 31, 2014, if declared by the Shareholders at the ensuing Annual General Meeting.12 May · Board meeting
9 May · Dividend
Board of Directors at their Meeting has recommended a final dividend of Rs. 5/- per equity share of Rs. 5/- each fully paid up further to the interim dividend of Rs. 5/- per equity share paid during the last quarter. These final dividend amounts, if declared by the Shareholders, are proposed to be paid / dispatched on or around August 04, 2014.
Apr 2014
Jan 2014
22 Jan · Dividend
Board of Directors of the Company at its meeting held on January 21, 2014 has declared an interim dividend of Rs. 5.00 per equity share of Rs. 5/- each fully paid up.22 Jan · Dividend
Dividend amounts will be paid / dispatched on February 03, 2014.21 Jan · Disclosure of Voting Pattern - Clause 35A
14 Jan · Corporate action
Company has fixed Record Date as January 27, 2014 for the purpose of payment of interim dividend, if declared by the Board.
Dec 2013
Nov 2013
22 Nov · News Verification
News Verification : The media had reports that "Torrent in talks to buy Elder India Biz". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Torrent Pharmaceuticals Limited has vide its letter inter-alia stated, "We would like to submit that the news item is speculative in nature and it is the company's policy not to respond to any such speculative news item. As a growing company, we do continuously explore business opportunities organic as well as inorganic. In line with this approach, the Company has submitted a non-exclusive bid for certain business of Elder subject to various assumption and conditions, not yet complied with. At this stage, therefore, there is no crystalised proposal. Hence the matter is premature."
Oct 2013
9 Oct · Board meeting
Inter alia, to consider & approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2013.
Jul 2013
31 Jul · Disclosure of Voting Pattern - Clause 35A
29 Jul · Management
Following changes in the directorate of the Company as approved by the Shareholders at their Annual General Meeting (AGM) held on July 26, 2013: (1) Dr. Prasanna Chandra has ceased to be a Director of the Company due to his retirement from the Board with effect from the conclusion of AGM above. (2) Shri. Sanjay Lalbhai has ceased to be a Director of the Company due to his retirement from the Board with effect from the conclusion of AGM above. (3) Shri. Pradeep Bhargava (who was earlier appointed as Additional Director by the Board of Directors at its meeting held on October 26, 2012) has been appointed as Director (Independent Non-Executive) of the Company w.e.f. July 26, 2013, liable to retire by rotation.27 Jul · Disclosure of Voting Pattern - Clause 35A
15 Jul · Corporate action
Company has fixed Record Date as July 24, 2013 for the purpose of issue and allotment of Bonus Shares, in the ratio of 1 (one) new fully paid-up Equity Share of Rs.5 each for every 1 (one) fully paid-up Equity Share of Rs.5 each of the Company.15 Jul · Disclosure of Voting Pattern - Clause 35A
9 Jul · Board meeting
Inter alia, to consider & approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the Quarter ended June 30, 2013.
Jun 2013
May 2013
31 May · Corporate action
Share Transfer Books and Register of Members of the Company will remain closed from June 12, 2013 to June 14, 2013(both days inclusive) for the purpose of purpose of final dividend for the year ended March 31, 2013, if declared at the ensuing Annual General Meeting.